These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35872753)

  • 21. Association of serum levels of FGF23 and α-Klotho with glomerular filtration rate and proteinuria among cardiac patients.
    Ozeki M; Fujita S; Kizawa S; Morita H; Sohmiya K; Hoshiga M; Ishizaka N
    BMC Nephrol; 2014 Sep; 15():147. PubMed ID: 25200959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.
    Shardlow A; McIntyre NJ; Fluck RJ; McIntyre CW; Taal MW
    BMJ Open; 2017 Aug; 7(8):e016528. PubMed ID: 28838895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble klotho and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
    Brandenburg VM; Kleber ME; Vervloet MG; Larsson TE; Tomaschitz A; Pilz S; Stojakovic T; Delgado G; Grammer TB; Marx N; März W; Scharnagl H
    Atherosclerosis; 2015 Oct; 242(2):483-9. PubMed ID: 26298739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of Ronghuang Granule on serum FGF23, FGFRs and Klotho in non-dialysis patients with CKD-MBD and kidney deficiency and damp-heat syndrome].
    Hu S; Wang D; Zhang R; Cao Y; Jin H; Mao Y; Wei L; Ren K; Zhang X; Wang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1427-1432. PubMed ID: 30613009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline FGF23 is Associated with Cardiovascular Outcome in Incident PD Patients.
    Kim HJ; Park M; Park HC; Jeong JC; Kim DK; Joo KW; Hwang YH; Yang J; Ahn C; Oh KH
    Perit Dial Int; 2016; 36(1):26-32. PubMed ID: 25185018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between Soluble
    Wang Q; Su W; Shen Z; Wang R
    Biomed Res Int; 2018; 2018():9481475. PubMed ID: 30159331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Potential application of fibroblast growth factor 23-klotho axis in chronic kidney disease].
    Lacroix JS; Urena-Torres P
    Nephrol Ther; 2020 Mar; 16(2):83-92. PubMed ID: 31843356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23.
    Navarro-García JA; Salguero-Bodes R; González-Lafuente L; Martín-Nunes L; Rodríguez-Sánchez E; Bada-Bosch T; Hernández E; Mérida-Herrero E; Praga M; Solís J; Arribas F; Bueno H; Kuro-O M; Fernández-Velasco M; Ruilope LM; Delgado C; Ruiz-Hurtado G
    BMC Med; 2022 Jan; 20(1):14. PubMed ID: 35042527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Fibroblast Growth Factor 23 With Risk of Incident Coronary Heart Disease in Community-Living Adults.
    Panwar B; Judd SE; Wadley VG; Jenny NS; Howard VJ; Safford MM; Gutiérrez OM
    JAMA Cardiol; 2018 Apr; 3(4):318-325. PubMed ID: 29516098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Correlations of FGF23 and Klotho with cardiovascular injury in chronic kidney disease patients].
    Gan L; Zhou Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 42(9):1058-1065. PubMed ID: 28989152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Clinical Value of Klotho and FGF23 in Cardiac Valve Calcification Among Patients with Chronic Kidney Disease.
    Chen Y; Chen YX; Huang C; Duan ZB; Xu CY
    Int J Gen Med; 2021; 14():857-866. PubMed ID: 33758533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A short story of Klotho and FGF23: a deuce of dark side or the savior?
    Ersoy FF
    Int Urol Nephrol; 2014 Mar; 46(3):577-81. PubMed ID: 24057685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association between soluble klotho and cardiovascular parameters in chronic kidney disease: results from the KNOW-CKD study.
    Kim HJ; Kang E; Oh YK; Kim YH; Han SH; Yoo TH; Chae DW; Lee J; Ahn C; Oh KH
    BMC Nephrol; 2018 Mar; 19(1):51. PubMed ID: 29506503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum Klotho, Cardiovascular Events, and Mortality in Nondiabetic Chronic Kidney Disease.
    Yang K; Yang J; Bi X; Yu Z; Xiao T; Huang Y; Liu Y; Xiong J; Zhao J
    Cardiorenal Med; 2020; 10(3):175-187. PubMed ID: 32294646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between cFGF23/Klotho ratio and phosphate levels in patients with chronic kidney disease.
    Liu Z; Zhou H; Chen X; Chen H; Wang Y; Wang T; Cai L; Hong Y; Ke H; Zheng J
    Int Urol Nephrol; 2019 Mar; 51(3):503-507. PubMed ID: 30689182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mediation of the relationship between proteinuria and serum phosphate: Insight from the KNOW-CKD study.
    Jung JY; Ro H; Chang JH; Kim AJ; Lee HH; Han SH; Yoo TH; Lee KB; Kim YH; Kim SW; Park SK; Chae DW; Oh KH; Ahn C; Chung W
    PLoS One; 2020; 15(6):e0235077. PubMed ID: 32569271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New insights into the FGF23-Klotho axis.
    Olauson H; Vervloet MG; Cozzolino M; Massy ZA; Ureña Torres P; Larsson TE
    Semin Nephrol; 2014 Nov; 34(6):586-97. PubMed ID: 25498378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroblast growth factor 23, mineral metabolism and mortality among elderly men (Swedish MrOs).
    Westerberg PA; Tivesten Å; Karlsson MK; Mellström D; Orwoll E; Ohlsson C; Larsson TE; Linde T; Ljunggren Ö
    BMC Nephrol; 2013 Apr; 14():85. PubMed ID: 23587028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibroblast growth factor 23 and Klotho as cardiovascular risk factors in heart transplant recipients.
    Przybylowski P; Wasilewski G; Janik L; Kozlowska S; Nowak E; Malyszko J
    Transplant Proc; 2014 Oct; 46(8):2848-51. PubMed ID: 25380933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.